Geode Capital Management’s Revolution Medicines RVMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$324M	Buy	3,338,142 +176,179	+6%	+$17.8M	0.02%	563
2025 Q4	$252M	Buy	3,161,963 +16,323	+0.5%	+$1.07M	0.02%	640
2025 Q3	$147M	Buy	3,145,640 +151,774	+5%	+$5.94M	0.01%	849
2025 Q2	$110M	Sell	2,993,866 -1,148,548	-28%	-$44.1M	0.01%	969
2025 Q1	$147M	Buy	4,142,414 +56,215	+1%	+$2.28M	0.01%	763
2024 Q4	$180M	Buy	4,086,199 +459,174	+13%	+$23.2M	0.01%	672
2024 Q3	$165M	Buy	3,627,025 +291,369	+9%	+$12.7M	0.01%	700
2024 Q2	$129M	Buy	3,335,656 +282,965	+9%	+$10.6M	0.01%	770
2024 Q1	$98.4M	Buy	3,052,691 +73,907	+2%	+$2.19M	0.01%	929
2023 Q4	$85.4M	Buy	2,978,784 +906,052	+44%	+$21.8M	0.01%	960
2023 Q3	$57.4M	Buy	2,072,732 +124,272	+6%	+$3.69M	0.01%	1141
2023 Q2	$52.1M	Buy	1,948,460 +214,383	+12%	+$5.26M	0.01%	1210
2023 Q1	$37.6M	Buy	1,734,077 +287,221	+20%	+$7.07M	﹤0.01%	1383
2022 Q4	$34.5M	Buy	1,446,856 +68,304	+5%	+$1.45M	﹤0.01%	1401
2022 Q3	$27.2M	Buy	1,378,552 +212,794	+18%	+$4.68M	﹤0.01%	1524
2022 Q2	$22.7M	Buy	1,165,758 +44,817	+4%	+$872K	﹤0.01%	1673
2022 Q1	$28.6M	Buy	1,120,941 +17,444	+2%	+$380K	﹤0.01%	1647
2021 Q4	$27.8M	Buy	1,103,497 +22,558	+2%	+$636K	﹤0.01%	1735
2021 Q3	$29.7M	Buy	1,080,939 +136,881	+14%	+$3.98M	﹤0.01%	1701
2021 Q2	$30M	Buy	944,058 +165,458	+21%	+$5.77M	﹤0.01%	1695
2021 Q1	$35.7M	Buy	778,600 +136,235	+21%	+$6.11M	0.01%	1484
2020 Q4	$25.4M	Buy	642,365 +16,265	+3%	+$643K	﹤0.01%	1571
2020 Q3	$21.8M	Buy	626,100 +370,940	+145%	+$10.3M	﹤0.01%	1481
2020 Q2	$8.05M	Buy	255,160 +134,282	+111%	+$4.22M	﹤0.01%	2062
2020 Q1	$2.65M	Buy	+120,878	New	+$3.35M	﹤0.01%	2519